Author:
Chang Jiang,Paillard Archibald,Passirani Catherine,Morille Marie,Benoit Jean-Pierre,Betbeder Didier,Garcion Emmanuel
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology
Reference71 articles.
1. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987–96.
2. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2007;2(12):751–60.
3. Sells RA, Owen RR, New RR, Gilmore IT. Reduction in toxicity of doxorubicin by liposomal entrapment. Lancet. 1987;2(8559):624–5.
4. Rahman A, Treat J, Roh JK, Potkul LA, Alvord WG, Forst D, et al. A phase I clinical trial and pharmacokinetic evaluation of liposome-encapsulated doxorubicin. J Clin Oncol. 1990;8(6):1093–100.
5. Cowens JW, Creaven PJ, Greco WR, Brenner DE, Tung Y, Ostro M, et al. Initial clinical (phase I) trial of TLC D-99 (doxorubicin encapsulated in liposomes). Cancer Res. 1993;53(12):2796–802.
Cited by
95 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献